Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: ICH E6(R3) updates

ICH E6(R3): Major Updates and What They Mean for Clinical Trials

Posted on May 9, 2025 digi By digi

ICH E6(R3): Major Updates and What They Mean for Clinical Trials Understanding the Impact of ICH E6(R3) Revisions on Clinical Trial Practices The International Council for Harmonisation’s Good Clinical Practice (GCP) guideline, ICH E6, is undergoing significant updates with the release of ICH E6(R3). These revisions aim to modernize clinical trial conduct, enhance data integrity,…

Read More “ICH E6(R3): Major Updates and What They Mean for Clinical Trials” »

ICH Guidelines, Regulatory Guidelines

Data Integrity Considerations Under ICH E6 Guidelines

Posted on May 7, 2025 digi By digi

Data Integrity Considerations Under ICH E6 Guidelines Ensuring Data Integrity in Clinical Trials under ICH E6 Guidance Data integrity lies at the heart of clinical trial credibility. Under the ICH E6 Good Clinical Practice (GCP) guideline, maintaining high-quality, reliable data is essential for protecting participant safety and ensuring scientific validity. Whether the trial data is…

Read More “Data Integrity Considerations Under ICH E6 Guidelines” »

ICH Guidelines, Regulatory Guidelines

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development
  • Cardiac Safety in Phase 1: QTc and Intensive ECG Monitoring
  • Endpoint Hierarchy Planning and Sensitivity Analyses in Phase 3 Trials: Ensuring Statistical Validity and Regulatory Confidence
  • Data Mining for Adverse Drug Reactions in Phase 4 Clinical Trials
  • Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme